SecBot SecBot
COURT-RULING ·Filed Jul 17, 2026

ATR

APTARGROUP, INC.
BULLISH
Impact 5/10
Horizonweeks Processed4mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight ▲ Bullish

This is a procedural win for AptarGroup that consolidates litigation in a favorable forum and increases settlement leverage. Monitor the consolidated case in SDNY for discovery rulings and summary judgment motions, which will determine the materiality of antitrust exposure.

DirectionBullish
Confidencehigh
Horizonweeks

Drug in focus

neffy

◆ Mixed Named in this court ruling
Impact
Phase
Approved and marketed (anaphylaxis/Type I allergic reactions); Phase 2b expansion for chronic spontaneous urticaria
Time to market
Already on the market — FDA approved Aug 9, 2024; label expanded March 2026 to all patients ≥33 lbs (no age cap); approved in Canada April 2026. The separate CSU (urticaria) indication is in Phase 2b and years from approval.
Next catalyst
None dated

What to watchThe single biggest swing factor is the CVS Caremark neffy coverage decision, now targeted for January 2027, the stock lost 23.9% in one day merely on the deferral, so a favorable January outcome could be a major re-rating catalyst and another delay a fresh leg down. Also watch the Q4 2026 Phase 2b CSU interim readout (new-indication upside) and quarterly neffy sales vs the heavy SG&A burn; analysts' ~$23 mean target is far above the ~$6.38 price, but litigation over coverage-timing disclosures is an unresolved overhang.

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$129.45
T+0 close · Jul 20, 2026 · via day close
Latest settled
−7.91%
T+60 · $119.21
Vs SPY
−13.01%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 20 $129.45entry
  2. T+1 · 4mo ago −0.77%α −1.60% · $128.46
  3. T+5 · 4mo ago +2.66%α +3.07% · $132.90
  4. T+20 · 3mo ago +1.77%α −2.35% · $131.74
  5. T+60 · 5w ago −7.91%α −13.01% · $119.21
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The court granted AptarGroup's motion to transfer ARS Pharmaceuticals' antitrust lawsuit to the Southern District of New York under the first-to-file rule, consolidating it with AptarGroup's earlier-filed trade secret and breach of contract case. This procedural win for AptarGroup avoids duplicative litigation and forces ARS's antitrust claims to be litigated in the same forum as AptarGroup's affirmative claims, potentially increasing settlement leverage for AptarGroup. No damages were awarded or pleaded in this ruling, and the underlying antitrust exposure remains unresolved but now faces a unified proceeding.

Court Ruling Details

Ruling Date
Jul 17, 2026
Court
United States District Court for the Southern District of California
Court Level
District
Case Type
antitrust
Ruling Type
motion to dismiss
Outcome
PARTIAL: mixed ruling, some claims won/lost
Precedent Risk
LOW

Key Facts

  • AptarGroup's motion to transfer ARS Pharmaceuticals' antitrust case to the Southern District of New York was granted under the first-to-file rule.
  • The court found the two cases (AptarGroup's trade secret/breach of contract suit and ARS's antitrust suit) involve substantially similar issues regarding the supply of neffy components.
  • The transfer consolidates both cases in the Southern District of New York, avoiding duplicative discovery and pretrial proceedings.
  • No damages were awarded or pleaded in this ruling; it is a procedural venue determination.
  • The underlying antitrust claims (tying and monopolization) remain pending but will now be litigated alongside AptarGroup's trade secret claims.

Financial Impact

No damages awarded or quantified in this ruling. The antitrust case remains pending with no stated exposure amount.

legal_expenseslitigation_risk

Risk Factors

  • The underlying antitrust claims (tying and monopolization) survive and will proceed in SDNY, maintaining litigation overhang.
  • AptarGroup's trade secret and breach of contract claims in the same case could result in countervailing liability if ARS prevails on antitrust theories.
  • Discovery in the consolidated case may reveal unfavorable facts about AptarGroup's supply policies.

Market Snapshot

Exchange
NYSE
Sector
Plastics Products, NEC
Analyst Consensus
75% bullish (12 analysts)

Investment Themes

Materials & Mining

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-117d8eab7a-ATR

Track record

12 reports on ATR

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 2, 202614d ago 144 Neutral 2/10 Entry $143.86 Now $143.17 −0.48% settles Dec 1
  2. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $137.20 Now $143.17 +4.35% settles Nov 30
  3. Oct 23, 202624d ago Institutional Cluster Neutral 3/10 Entry $126.55 Now $143.17 +13.13% settles Nov 20
  4. Sep 21, 20268w ago 8-K Bearish 4/10 Entry $125.45 to $125.77 Now $143.17 −14.13% ▼ −0.26% −0.81% vs SPY
  5. Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $128.31 to $121.16 Now $143.17 +11.58% ▼ −5.57% −4.45% vs SPY
  6. Sep 1, 202610w ago 8-K Neutral 2/10 Entry $130.92 to $121.44 Now $143.17 +9.36% ▼ −7.24% −8.42% vs SPY
  7. Aug 5, 202614w ago Insider Cluster Neutral 3/10 Entry $135.78 to $128.31 Now $143.17 +5.44% ▼ −5.50% −6.10% vs SPY
  8. Aug 4, 202614w ago Insider Cluster Neutral 3/10 Entry $136.18 to $130.92 Now $143.17 +5.13% ▼ −3.86% −2.62% vs SPY
  9. Jul 17, 202617w ago Court Ruling Bullish 5/10 Viewing Entry $129.45 to $131.74 Now $143.17 +10.60% ▲ +1.77% −2.35% vs SPY
  10. Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $114.67 to $124.45 Now $143.17 +24.85% ▲ +8.53% +4.91% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 8h 55m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Jul 19, 2026